Editor’s Note: Today’s post comes from contributing editor Brooks Hudson, a PhD candidate in history at Southern Illinois University.
The Atlantic, as one critic remarked, “perfectly captures…the puzzled dining club member’s approach to civic and political organizing, and the all-around obtuseness of elite discourse”; it is an “ideological compromised organ of beltway consensus.” Matt Christman, of Chapo Trap House fame, quipped in one episode that The Atlantic is “neoliberal Dabiq,” a death-cult of discredited ideas concealed in a glossy facade. Jeffrey Goldberg, the Atlantic‘s editor-in-chief, was an early and enthusiastic promoter of the Iraq War, injecting into the bloodstream such fantasies as the collaboration between Saddam Hussein and Al Qaeda. His journalistic style, as one watchdog organization put it, was “complete with cherry-picked evidence, dubious inferences, rejection of contradictory evidence and ideological blinders.”
Don’t get me wrong, The Atlantic isn’t total garbage, but, like a kitchen after Thanksgiving, garbage is involved.
By that I mean that the Atlantic has a tendency to generate two kinds of content: the inane and the disingenuous. An example of the former: attributing “bigotry on the right,” to the left. Another example: solving New York’s subway system à la hoverboards.
But Annie Lowrey’s recent article, “America’s Invisible Pot Addicts,” isn’t inane, just disingenuous.
Continue reading →
Editor’s Note: You can see Lucia Romero discuss her work on grassroots mobilization for access to medical cannabis in Argentina below. This builds on her post, published Tuesday, and wraps up our content from the excellent Cannabis: Global Histories conference. All videos were produced by Morgan Scott of Breathe Images. Enjoy!
Editor’s Note: This is the last post in our series from the Cannabis: Global Histories conference, held at the University of Strathclyde from April 19-20, 2018. It comes from Lucia Romero, an assistant researcher at CONICET (Argentina’s National Scientific and Technical Research Council). In it, she explores the grassroots groups that overcame decades of prohibition to increase access to medical marijuana in Argentina. Enjoy!
This paper discusses the rise of therapeutic cannabis use in Argentina. Through documentary work and personal interviews, our sociological approach focuses on how users (patients, growers) and experts (scientists, doctors, lawyers) produce and exchange different types of knowledge related to this medicine.
Our starting point was the recent medicinal cannabis law sanctioned in Argentina. Although cannabis has been socially signified as a drug and ruled illegal in the country for decades, over the course of two years, we have seen an accelerated process of social, medical, scientific and political legitimation of medicinal cannabis, which was concluded with the approval of a national law in March 2017. This law stipulates a regulatory framework for medical and scientific research and administrative resources to import cannabis oil for epilepsy patients, while private and designated cultivation remains illegal. This topic was, and is still, a central cause of conflict and political fights carried out by activists for health cannabis, as they and the growers are excluded from the law (many activists for health cannabis practice and promote self cultivation).
Dr. Lucia Romero presents her work at the Cannabis: Global Histories conference at the University of Strathclyde, April 2018. Photo by Morgan Scott, Breathe Images
Continue reading →
Editor’s Note: Today’s post comes from Dr. Suzanne Taylor, Research Fellow at the Centre for History in Public Health, London School of Hygiene & Tropical Medicine, and is based off of her presentation at the Cannabis: Global Histories conference, held at the University of Strathclyde, Glasgow, on April 19-20, 2018. In it, she explores the role of lay knowledge and social activism in transforming cannabis into a legitimate medical substance from the 1970s to today.
Alfie Dingley, the face of medical cannabis in the UK
In March 2018, the case of Alfie Dingley, a six year old boy with epilepsy, hit the headlines as his mother campaigned for access to cannabis oil to help alleviate his seizures.  But what was the background to activism for access to cannabis on medical grounds? When cannabis-based medicine was withdrawn in the UK in 1973 it appeared that cannabis’s career as a medicine had ended, but, even as cannabis became regulated solely as an illicit drug, it was being re-medicalized. Within ten years of cannabis tinctures’ removal, synthetic cannabis-based drugs entered the clinic. However, these drugs caused serious side effects, were expensive and difficult to access, and so were little used. In the UK in the late 1990s the development of a cannabis-based drug using extracts from cannabis appeared to offer a potential way forward, and in 2006 the Home Office licensed GW Pharmaceuticals’ drug, Sativex, on a named-patient basis but it has not been widely available. In 2015 the report Regulating Cannabis for Medical Use in the UK claimed that British patients were “suffering unnecessarily” and argued for the rescheduling of cannabis to enable its prescription and facilitate research.
Dr. Suzanne Taylor presents her work at the Cannabis: Global Histories conference, April 20, 2018, at the University of Strathclyde, Glasgow. Photo by Morgan Scott, Breathe Images
Continue reading →
Editor’s Note: Did you hear? Yesterday, Canada’s Senate passed legislation legalizing recreational marijuana use for adults. Legalization will officially take place in October 17, 2018, in an effort to “take market share away from organized crime and protect the country’s youth,” Prime Minister Justin Trudeau said. Do you think Canada passed the law because they read Matthew DeCloedt’s post, published on Tuesday, about human rights arguments that advanced the passage of Canadian medical marijuana laws years before? Probably! Here’s more from DeCloedt in a video taken at the Cannabis: Global Histories conference, so you can hear the man himself explain his research and work. Enjoy!
Matthew DeCloedt – Global Histories: Cannabis from Points ADHS on Vimeo.
Editor’s Note: Today’s post comes from Matthew DeCloedt, a law student at Central European University and a participant in the Cannabis: Global Histories conference held from April 19-20, 2018, at the University of Strathclyde, Glasgow. DeCloedt brings a legal lens to the conversation surrounding medical marijuana in Canada, with a specific focus on human rights. Enjoy!
To understand how Canada went from limited access to cannabis for therapeutic purposes to the impending legalization of recreational pot, it is crucial to understand the impact of human rights discourse on the erosion of impediments to accessing medical cannabis.
From the early 2000s, Canadian courts were a crucial forum for taking issue with the federal government’s restrictive cannabis law and policy.
Section 7 of the Canada Charter of Rights and Freedoms, which gives “Everyone…the right to life, liberty and the security of person,” was the most important of the rights invoked by litigants.
The success and failure of human rights claims depended on Canadian litigants’ ability to convince the courts that the threat of criminal sanctions for possessing and cultivating cannabis for therapeutic purposes violated their right to life, liberty and security of person. In other words, they asked whether prohibition was a proportional response to the supposed harms of using cannabis?
Continue reading →
Anyone tuning in to Fox & Friends this week was treated to an awkward moment courtesy of Dr. Oz, when he went off-script after plugging his upcoming interview with Ivanka Trump and launched into an impassioned defense of medical marijuana.
“Can I ask you one thing? I talked about the opioid epidemic, but the real story is the hypocrisy around medical marijuana. And just really quickly, medical marijuana – people think it’s a gateway drug to narcotics but it may be the exit drug to get us out of the narcotic epidemic. But we’re not allowed, we’re not allowed to study it, because it’s a schedule I drug. And personally, I believe it could help.”
“Wow,” co-host Steve Doocy intoned, visibly tense. “Hadn’t heard that before.” He reminded viewers to watch Oz’s show and cut to commercial break, clearly wishing the cardiologist had taken co-host Brian Kilmeade’s cue to end the segment twenty seconds prior. Continue reading →